🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
An open label, balanced, randomized, single dose, two treatment, two sequen...
Status
Completed
Location
Veeda Clinical Research Ltd.
Start Date
2024-12-23
Trial ID
NCT06932159
Treatments Being Tested
The purpose of this research study is to evaluate the efficacy and safety o...
Status
Completed
Location
Phoenix Children's Hospital
Start Date
2018-03-20
Trial ID
NCT03429543
Treatments Being Tested
The efficacy and safety of a triple-pill combination therapy for advanced t...
Status
Recruiting
Location
Faisalabad clinics
Start Date
2025-10-30
Trial ID
NCT06862739
Treatments Being Tested
The study titled "Efficacy and Safety of Omarigliptin, A Weekly Dipeptidyl ...
Status
Unknown
Location
BIRDEM General Hospital
Start Date
2024-09
Trial ID
NCT06449235
Three SGLT2i were commercially available in Italy at the time the trial was...
Status
Unknown
Location
Multiple Locations
Start Date
2021-06-30
Trial ID
NCT04796428
Treatments Being Tested
An open label, randomized, two-period, two treatment, two-sequence, crossov...
Status
Completed
Location
Cliantha Research Limited
Start Date
2026-03-07
Trial ID
NCT07691203
Treatments Being Tested
In the early postoperative period, hyperglycemia is frequently seen in rena...
Status
Recruiting
Location
Division Of Endocrinology & Diabetes, Medanta The Medicity
Start Date
2023-10-30
Trial ID
NCT06095492
Treatments Being Tested
We will look for the possible effect of SGLT2i as a single agent to prevent...
Status
Unknown
Location
Multiple Locations
Start Date
2021-07-01
Trial ID
NCT04853615
Treatments Being Tested
Diabetes mellitus is a wide-spread disease accompanied by strongly increase...
Status
Completed
Location
Clinical Research Center, Dept of Nephrology and Hypertenison, University of Erlangen/Nürnberg
Start Date
2016-04
Trial ID
NCT02752113
Treatments Being Tested
The objective of the study is to investigate the efficacy, safety and toler...
Status
Completed
Location
1275.10.01019 Boehringer Ingelheim Investigational Site
Start Date
2013-01
Trial ID
NCT01778049